Who
William Frank Hulse IV
General Counsel and CAO
Company insider
Files Form 4 as: General Counsel and CAO, MiMedx Group.
In numbers
- Trades disclosed
- 38
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $1.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Aug 2020
- Last trade
- 13 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Mar 2026filed 17 Mar 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code F | $89K20,245 at $4.38 | filing |
| 13 Mar 2026filed 17 Mar 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code F | $89K20,245 at $4.38 | filing |
| 10 Mar 2026filed 12 Mar 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code M | $614K136,364 at $4.50 | filing |
| 10 Mar 2026filed 12 Mar 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code F | $277K61,460 at $4.50 | filing |
| 10 Mar 2026filed 12 Mar 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code M | $614K136,364 at $4.50 | filing |
| 10 Mar 2026filed 12 Mar 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code F | $277K61,460 at $4.50 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | —74,987 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MDXG MiMedx Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —62,758 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MDXG MiMedx Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —62,758 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | —74,987 at $0.00 | filing |
| 8 May 2025filed 16 May 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code F | $66K8,877 at $7.42 | filing |
| 23 Apr 2025filed 25 Apr 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code F | $60K8,876 at $6.76 | filing |
| 8 Apr 2025filed 10 Apr 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code F | $61K8,876 at $6.86 | filing |
| 13 Mar 2025filed 14 Mar 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Sold | $270K34,230 at $7.89 | filing |
| 13 Mar 2025filed 14 Mar 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Sold | $161K20,366 at $7.89 | filing |
| 10 Mar 2025filed 12 Mar 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Sold | $635K81,446 at $7.80 | filing |
| 3 Mar 2025filed 5 Mar 2025 | MDXG MiMedx Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —36,891 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | —76,510 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | —46,439 at $0.00 | filing |
| 8 May 2024filed 9 May 2024 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code F | $64K8,896 at $7.20 | filing |
News
Financial Comparison: MiMedx Group (NASDAQ:MDXG) versus BioNTech (NASDAQ:BNTX)MDXG · themarketsdaily.com · 21 Oct 2026
0 headlines in the last 90 days name William Frank Hulse IV; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.